CVS Health Corp. (NYSE: CVS) delivered a strong earnings report on Aug. 5, but one note revealed on the earnings conference call sent CVS down 5% in trading that day.
In the long run, that note shouldn’t impact what was otherwise a strong beat-and-raise quarter. However, CVS is up over 50% in the last 12 months and more than 20% in 2026. There were whispers of the stock being “priced for perfection” heading into the report.
